Taking the High Out of Pain: Exploring Abuse-Deterrent Opioids and Opioid Alternatives

February 1, 2019

More than 650,000 opioids are dispensed in the US with nearly 4,000 people consuming a prescription opioid for non-medical use, leading to 78 deaths each day from an opioid-related overdose.

Spotlight

Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 million packages.

Other Infographics
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More
news image

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Read More

Spotlight

Grupo Medinfar

MEDINFAR is a fully integrated Portuguese Pharmaceutical Company headquartered in Lisbon. Founded in 1970, MEDINFAR is focused in R&D, Production, Distribution, Marketing & Sales. Besides its own brands it markets licensed products in partnerships with several top international pharmaceutical companies. MEDINFAR is the Nº1 Portuguese Company in Dermatology as in Consumer Health. MEDINFAR has a wide range of products from Prescription Medicines to Generics, OTC/Consumer Health products and veterinary products. In 2001, with the acquisition of the manufacturing unit, FARMALABOR, Medinfar increased its productive capacity. This unit has an area of 47.000 m2 and produced in 2013 around 15 million packages.

Events